Monday, 2 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Latest announcements

Every corporate announcement our alert engine sent, newest first: orders, results, earnings calls, fund raises, board meetings and more.

09:01 IST BSE
Fund RaiseSteel Exchange India Ltd STEELXIND

Steel Exchange India Fund Raise of ₹40.32 Cr

Steel Exchange India Limited announced a ₹40.32 Crore capital infusion. This includes a ₹10.40 Crore allotment of 4.40 crore fresh convertible warrants and ₹29.92 Crore from the conversion of 2.82 crore existing warrants into equity. The funds will strengthen the company's capital base, support operational expansion, and improve financial flexibility.

Value
₹40.32 Cr
08:54 IST BSE
Production StartedLloyds Metals & Energy Ltd LLOYDSME

Lloyds Metals & Energy Production Started

Lloyds Metals and Energy successfully commissioned its second 4 MTPA pellet plant at Konsari, Maharashtra, in a record 16 months. This doubles the company's total pellet capacity to 8 MTPA, establishing it as a leading merchant pellet player. The plant utilizes feedstock from captive mines via an 85-km slurry pipeline, enhancing the company's integrated steel value chain.

Execution
16 months
08:36 IST BSE
Business UpdateAdani Ports & Special Economic Zone Ltd ADANIPORTS

Adani Ports & Special Economic Zone Business Update

Adani Ports and Special Economic Zone Ltd (APSEZ) handled 43.1 MMT of cargo in April 2026, marking a 15% YoY growth. Growth was driven by container and dry cargo volumes, both increasing 17%. Logistics rail volume stood at 48,490 TEUs, a 16% YoY decline. The performance indicates strong momentum in core port operations.

08:27 IST BSE
Regulatory ApprovalOneSource Specialty Pharma Ltd ONESOURCE

OneSource Specialty Pharma Regulatory Approval

OneSource Specialty Pharma's partner, Orbicular, received Health Canada approval for a generic version of Ozempic (semaglutide). This marks the second generic semaglutide approval in Canada, the world's second-largest market for the drug. OneSource will support commercial supply from its FDA-approved Bengaluru facility, strengthening its global CDMO position in complex injectables.

23:21 IST BSE
Financial ResultsRajeswari Infrastructure Ltd RAJINFRA

Rajeswari Infrastructure Financial Results

Rajeswari Infrastructure Limited reported audited standalone financial results for the year ended March 31, 2026. The company posted a net loss of ₹13.05 Lakhs for the full year. The Monitoring Committee, overseeing operations following the NCLT-approved resolution plan, adopted the results on a going concern basis. The statutory auditor issued a disclaimer of opinion.

23:14 IST BSE
Financial ResultsRajeswari Infrastructure Ltd RAJINFRA

Rajeswari Infrastructure Financial Results

Rajeswari Infrastructure Ltd reported standalone results for Q3 FY2026, posting a net loss of ₹3.65 Lakhs on total income of ₹0.03 Lakhs. The company is currently managed by a Monitoring Committee following the approval of a resolution plan under CIRP. Financial statements were prepared on a going concern basis despite auditor's disclaimer of opinion.

23:09 IST BSE
Financial ResultsRajeswari Infrastructure Ltd RAJINFRA

Rajeswari Infrastructure Financial Results

Rajeswari Infrastructure Ltd reported unaudited financial results for the quarter ended September 30, 2025, with a net loss of ₹3.05 Lakhs. The company is under the Corporate Insolvency Resolution Process (CIRP). The statutory auditor issued a disclaimer of opinion due to insufficient audit evidence regarding opening balances, inventories, and liabilities under the resolution plan.

23:09 IST BSE
Financial ResultsRajeswari Infrastructure Ltd RAJINFRA

Rajeswari Infrastructure Financial Results

Rajeswari Infrastructure Ltd reported standalone financial results for the quarter ended June 30, 2025. The company remains under a Monitoring Committee following its Corporate Insolvency Resolution Process (CIRP). The statutory auditor issued a Disclaimer of Opinion citing insufficient evidence regarding opening balances, going concern assumptions, and asset valuations.